As the coronavirus continues its deadly rampage with nearly 1,400 people deceased and over 48’000 infected across China, pharmaceutical companies and scientists are working diligently on new treatments and vaccines against the virus. At the moment China has more than 80 running or pending clinical trials on potential treatments for COVID-19. This has resulted in an increased transport volume of antivirals and experimental drugs to China. In order to meet the urgent demand for these products, the pharmaceutical companies have to send the life-saving products by air freight, which has its own risks. International air freight routes into China are complex, and it must be ensured that medicines are not spoiled by temperature excursions throughout the supply chain.